Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Capital Employed: 2016-2025

Historic Return on Capital Employed for Assembly Biosciences (ASMB) over the last 8 years, with Sep 2025 value amounting to -0.41%.

  • Assembly Biosciences' Return on Capital Employed rose 30.00% to -0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.41%, marking a year-over-year increase of 30.00%. This contributed to the annual value of -0.57% for FY2024, which is 24.00% up from last year.
  • Per Assembly Biosciences' latest filing, its Return on Capital Employed stood at -0.41% for Q3 2025, which was up 60.25% from -1.02% recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Return on Capital Employed ranged from a high of -0.24% in Q1 2021 and a low of -2.21% during Q3 2023.
  • For the 3-year period, Assembly Biosciences' Return on Capital Employed averaged around -1.05%, with its median value being -0.73% (2024).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by 41bps in 2021, then surged by 151bps in 2024.
  • Assembly Biosciences' Return on Capital Employed (Quarterly) stood at -0.65% in 2021, then reached -1.18% in 2023, then skyrocketed by 44bps to -0.73% in 2024, then grew by 30bps to -0.41% in 2025.
  • Its Return on Capital Employed stands at -0.41% for Q3 2025, versus -1.02% for Q2 2025 and -0.71% for Q1 2025.